Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Besylate for ICU Sedation in Mechanically Ventilated Patients
ChiCTR2600123386Phase 4Completed
- Sponsor
- The Second Hospital of Shanxi Medical University
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in critical illness, respiratory failure, delirium and 1 more (2 arms), sponsored by The Second Hospital of Shanxi Medical University. Primary endpoints: Delirium, Richmond Agitation-Sedation Scale (RASS) score and 3 more. Started Apr 2026; status: completed.
02
Drugs
remimazolam
03
Conditions
critical illnessrespiratory failuredeliriumpain
Beyond the preview
Go deeper on ChiCTR2600123386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123386.